Pfizer may have been making headlines with the COVID vaccine it developed with BioNTech, but it’s not the only infectious disease the big pharma is targeting.
The healthcare system is running at its limits in many countries worldwide. One reason is the growing demand for healthcare, largely driven by the rise of chronic diseases.
Mike Dixon, CEO of the Healthcare Communications Association, discusses the biggest challenges facing the sector during and after COVID, from digital innovation to talent and sustainability